These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 6433609

  • 1. Biochemical characterization of ketosis-resistant young diabetics of northern India. In vivo effects of i.v. glucose, s.c. epinephrine and i.v. glucagon and in vitro effects of anti-insulin serum on adipose tissue lipolysis.
    Krishna Ram B, Sachdev G, Chopra A, Karmarkar MG.
    Acta Diabetol Lat; 1984; 21(2):141-51. PubMed ID: 6433609
    [Abstract] [Full Text] [Related]

  • 2. Effects of different plasma glucose concentrations on lipolytic and ketogenic responsiveness to epinephrine in type I (insulin-dependent) diabetic subjects.
    Avogaro A, Gnudi L, Valerio A, Maran A, Miola M, Opportuno A, Tiengo A, Bier DM.
    J Clin Endocrinol Metab; 1993 Apr; 76(4):845-50. PubMed ID: 8473394
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of free fatty acids, insulin, glucagon and adrenaline on ketone body production in humans.
    Miles JM, Haymond MW, Gerich JE.
    Ciba Found Symp; 1982 Apr; 87():192-213. PubMed ID: 7042239
    [Abstract] [Full Text] [Related]

  • 7. The effects of different plasma insulin concentrations on lipolytic and ketogenic responses to epinephrine in normal and type 1 (insulin-dependent) diabetic humans.
    Avogaro A, Valerio A, Gnudi L, Maran A, Miola M, Duner E, Marescotti C, Iori E, Tiengo A, Nosadini R.
    Diabetologia; 1992 Feb; 35(2):129-38. PubMed ID: 1547916
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Enhanced glycemic responsiveness to epinephrine in insulin-dependent diabetes mellitus is the result of the inability to secrete insulin. Augmented insulin secretion normally limits the glycemic, but not the lipolytic or ketogenic, response to epinephrine in humans.
    Berk MA, Clutter WE, Skor D, Shah SD, Gingerich RP, Parvin CA, Cryer PE.
    J Clin Invest; 1985 Jun; 75(6):1842-51. PubMed ID: 3891786
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of epinephrine and somatostatin-induced insulin deficiency on ketone body kinetics and lipolysis in man.
    Weiss M, Keller U, Stauffacher W.
    Diabetes; 1984 Aug; 33(8):738-44. PubMed ID: 6146545
    [Abstract] [Full Text] [Related]

  • 16. Resistance to ketosis in moderately obese patients: influence of fatty liver.
    Inokuchi T, Orita M, Imamura K, Takao T, Isogai S.
    Intern Med; 1992 Aug; 31(8):978-83. PubMed ID: 1477471
    [Abstract] [Full Text] [Related]

  • 17. Modulation of fatty acid metabolism by glucagon in man. II. Effects in insulin-deficient diabetics.
    Schade DS, Eaton RP.
    Diabetes; 1975 May; 24(5):510-5. PubMed ID: 805077
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effects of physiologic levels of glucagon and growth hormone on human carbohydrate and lipid metabolism. Studies involving administration of exogenous hormone during suppression of endogenous hormone secretion with somatostatin.
    Gerich JE, Lorenzi M, Bier DM, Tsalikian E, Schneider V, Karam JH, Forsham PH.
    J Clin Invest; 1976 Apr; 57(4):875-84. PubMed ID: 820717
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.